摘要
目的:探讨阿托西班应用于早产时其药品不良反应/事件(ADR/ADE)的表现及发生规律,为其临床合理用药提供参考。方法:全面检索该药用于防治早产的所有国内、外临床研究,并对其出现的母体与新生儿ADR/ADE分别进行系统整理与分析。结果:阿托西班涉及母体的ADR/ADE主要为用药部位损害(47.11%)、胃肠系统损害(22.99%)、心率及心律紊乱(7.93%)、代谢和营养障碍(6.68%)等,具体表现为注射部位局部反应、恶心、呕吐、高血糖、心动过速等;涉及新生儿的ADR/ADE主要为呼吸系统损害(44.80%)、心外血管系统损害(9.27%)、胎儿异常(8.99%)及代谢和营养障碍(8.85%),具体表现为新生儿呼吸窘迫综合征、窒息、脑出血、动脉导管开放、低血糖、脓毒病、贫血等。阿托西班在东亚人群中最常见的不良反应为高血糖(7.25%)、心动过速(3.62%)、恶心(2.17%)、头痛(2.17%)、胸痛(2.17%)、呼吸困难(1.45%)及心悸(1.45%)等。结论:阿托西班在防治早产时可发生多种ADR/ADE,临床应用时需重视其安全性。
OBJECTIVE: To analyze and investigate the manifestations and regularity of adverse drug reactions/effects (ADR/ ADE) of atosiban applied in preterm labor, and to provide reference for rational drug use in the clinic. METHODS: Clinical trails about atosiban in the treatment of preterm labor were collected at home and abroad, maternal and neonatal/infant ADR/ADE of ato- siban were summarized and analyzed. RESULTS: The maternal ADR/ADE primarily contained application site disorders (47.11%), gastro-intestinal system disorders (22.99%), heart rate disorder or arrhythmia (7.93%), metabolism disorder and al- ogotrophy (6.68%), etc., presenting as application site reactions, nausea, vomiting, hyperglycemia, tachycardia, etc. The infant ADR/ADE mainly contained respiratory system damage (44.80%), vascular damage (9.27%), fetal abnormality (8.99%) and me- tabolism disorder and alogotrophy (8.85%), presenting as respiratory distress syackome, ap^ea, eerebra~ hemorrhage, patent due- ms arteriosus, hypoglycemia, sepsis, anaemia, etc. The most frequently occurred ADR/ADEs of atosiban in East Asian population were hyperglycemia (7.25%) , tachycardia (3.62%), nausea (2.17%), headache (2.17%), chest pain (2.17%), dyspnoea ( 1.45% ) and palpitation ( 1.45% ), etc. CONCLUSIONS: Atosiban can cause a variety of ADR/ADE in the treatment of preterm la- bor, so we should pay attention to its clinical safety.
出处
《中国药房》
CAS
CSCD
2014年第14期1304-1307,共4页
China Pharmacy